Patent ID: 11873339
Assignee: PIERRE FABRE MEDICAMENT
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C

Claim 23:
24. The method of claim 23, wherein
the enzyme is selected from the group consisting of horseradish peroxidase, alkaline phosphatase, beta-galactosidase, and acetylcholinesterase,
the fluorescent compound is selected from the group consisting of umbelliferone, fluorescein, fluorescein isothiocynate, rhodamine, dichlorotriazinylamine fluorescein, dansyl chloride and phycoerythrin,
the bioluminescent compound is selected from the group consisting of luciferase, luciferin, and aequorin,
the chemiluminescent compound is luminol, or
the radioisotope is selected from the group consisting of 131I, 125I, 123I, 121I, 14C, 35S, 3H, 115In, 113In, 112In, 111In, 99Tc, 201Ti, 68Ga, 67Ga, 103Pd, 99Mo, 133Xe, 18F, 153Sm, 177Lu, 159Gd, 149Pm 140La, 175Yb, 166Ho, 90Y, 47Sc, 186Re, 188Re, 142Pr, 105Rh, 97Ru, 68Ge, 57Co, 65Zn, 85Sr, 32P, 153Gd, 169Yb, 51Cr, 54Mn, 75Se, 113Sn, and 117Sn.